Annual report pursuant to Section 13 and 15(d)

Note 12 - Segment Information (Tables)

v3.19.3
Note 12 - Segment Information (Tables)
12 Months Ended
Jun. 30, 2019
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Year Ended June 30,
 
   
201
9
   
201
8
   
201
7
 
Net sales:
                       
Protein Sciences
  $
543,159
    $
482,378
    $
419,365
 
Diagnostics and Genomics
   
171,674
     
161,151
     
143,742
 
Intersegment
   
(827
)
   
(536
)
   
(104
)
Consolidated net sales
  $
714,006
    $
642,993
    $
563,003
 
                         
Operating Income:
                       
Protein Sciences
  $
240,919
    $
209,880
    $
184,095
 
Diagnostics and Genomics
   
10,079
     
35,496
     
29,291
 
Segment operating income
   
250,998
     
245,376
     
213,386
 
Costs recognized upon sale of acquired inventory
   
(3,739
)
   
(2,455
)
   
(3,037
)
Amortization of acquired intangible assets
   
(58,550
)
   
(46,983
)
   
(44,393
)
Acquisition related expenses
   
(2,282
)
   
(24,429
)
   
(25,789
)
Restructuring costs
   
-
 
   
(376
)
   
-
 
Stock-based compensation
   
(33,057
)
   
(28,240
)
   
(14,631
)
Corporate general, selling and administrative expenses
   
(6,651
)
   
(6,715
)
   
(4,952
)
Consolidated operating income
  $
146,719
    $
136,178
    $
120,584
 
   
Year Ended June 30,
 
   
201
9
   
201
8
   
201
7
 
Consumables revenue - Protein Sciences   $
430,655
    $
384,350
    $
341,611
 
Consumables revenue - Diagnostics and Genomics
   
158,324
     
150,388
     
134,930
 
Total consumable revenue
  $
588,979
    $
534,738
    $
476,541
 
   
Year ended June 30,
 
Long-lived assets:
 
201
9
   
201
8
 
United States and Canada
  $
138,016
    $
129,360
 
Europe
   
14,439
     
14,597
 
Asia
   
1,584
     
1,391
 
Total long-lived assets
  $
154,039
    $
145,348
 
Intangible assets:
               
United States and Canada
  $
556,951
    $
417,430
 
Europe
   
16,637
     
21,386
 
Asia
   
5,841
     
7,516
 
Total intangible assets
  $
579,429
    $
446,332